JOHNSON & JOHNSON
JNJNYSETrading Snapshot
- Day Range
- $264.20 – $272.75
- 52-Week Range
- $184.66 – $281.07
- Volume (shares)
- 6,312,609
- Avg Volume (shares)
- —
- Shares Outstanding
- 2.41B
- Next Earnings
- 2027-01-20
Fundamentals Snapshot
- Annual Revenue
- $94.19B
- Last Q Revenue
- $25.40B
- P/E Ratio
- 39.8
- P/S Ratio
- 6.4x
- EPS (TTM)
- $6.59
- Dividend Yield
- 1.97%
- Dilution (1yr)
- +0.5%
JOHNSON & JOHNSON
JNJ
StockOtter · stockotter.spaceAbout JOHNSON & JOHNSON
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Ratings
ⓘLatest News & Updates
Why JEPI’s Total Return Has Outpaced Its Payout
JEPI's share price keeps climbing while its monthly cash payments quietly shrink, and the reason behind that split reveals something most income investors never check before buying a covered-call fund.
Johnson & Johnson $JNJ Stock: Bernardo Wealth Planning LLC Raises Holdings
Bernardo Wealth Planning LLC boosted its position in shares of Johnson and Johnson (NYSE: JNJ) by 105.8% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commiss
29,241 Shares of Johnson & Johnson $JNJ Acquired by BG Investment Services LLC
BG Investment Services LLC acquired a new position in shares of Johnson and Johnson (NYSE: JNJ) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commi
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Johnson & Johnson - JNJ
NEW YORK, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Johnson & Johnson (“J&J” or the “Company”) (NYSE: JNJ). Such investors are advised to contact Danielle Peyton at
Medtronic Has Raised Its Dividend for 49 Years. These 2 Rivals Have Even Longer Streaks
Medtronic's 49-year dividend streak sounds impressive until you meet the two medical device rivals that have been raising payouts even longer, and the differences in yield, valuation, and balance sheet strength could res
4 Arthritis Drug Stocks Investors Should Monitor for Growth Potential
LLY, NVS, JNJ and ABBV offer arthritis drug growth potential through rising sales, regulatory approvals and clinical advances across inflammatory joint diseases.